US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

IMAB

I MAB (IMAB)

I MAB

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMAB

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/21	21 : 00	PR Newswire (US)	I-Mab to Participate at the Piper Sandler Healthcare Conference	NASDAQ:IMAB	I MAB
2024/11/14	21 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/11/14	21 : 00	PR Newswire (US)	I-Mab Reports Third Quarter 2024 Results	NASDAQ:IMAB	I MAB
2024/11/06	21 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/11/06	21 : 00	PR Newswire (US)	I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer	NASDAQ:IMAB	I MAB
2024/11/06	06 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/10/31	20 : 00	PR Newswire (US)	I-Mab to Release Q3 2024 Financial Results on November 14, 2024	NASDAQ:IMAB	I MAB
2024/10/30	20 : 00	PR Newswire (US)	I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024	NASDAQ:IMAB	I MAB
2024/10/28	20 : 00	PR Newswire (US)	I-Mab to Participate at the Truist Securities BioPharma Symposium	NASDAQ:IMAB	I MAB
2024/10/24	20 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/09/23	20 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/09/17	05 : 01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/09/17	05 : 01	PR Newswire (US)	I-Mab Presents Updated Phase 1 Givastomig Data at ESMO 2024	NASDAQ:IMAB	I MAB
2024/09/10	20 : 00	PR Newswire (US)	I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung Cancer	NASDAQ:IMAB	I MAB
2024/08/31	04 : 23	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/08/28	20 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/08/28	20 : 00	PR Newswire (US)	I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates	NASDAQ:IMAB	I MAB
2024/08/26	20 : 00	PR Newswire (US)	I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:IMAB	I MAB
2024/08/14	20 : 00	PR Newswire (US)	I-Mab to Release 1H 2024 Financial Results on August 28, 2024	NASDAQ:IMAB	I MAB
2024/08/07	20 : 59	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/08/07	20 : 00	PR Newswire (US)	I-Mab Appoints U.S. Auditor, PricewaterhouseCoopers LLP (PwC)	NASDAQ:IMAB	I MAB
2024/07/26	19 : 20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
2024/07/17	19 : 24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IMAB	I MAB
2024/07/15	20 : 45	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/07/15	20 : 30	PR Newswire (US)	I-Mab Announces Leadership Transitions	NASDAQ:IMAB	I MAB
2024/06/06	20 : 14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/06/06	20 : 00	PR Newswire (US)	I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer	NASDAQ:IMAB	I MAB
2024/06/05	20 : 11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IMAB	I MAB
2024/06/05	20 : 00	PR Newswire (US)	I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers	NASDAQ:IMAB	I MAB
2024/05/31	06 : 33	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IMAB	I MAB

Showing the most relevant articles for your search:NASDAQ:IMAB

1 2 3 4 5 6 7 8 9 10 次へ >>

Gold vs US Dollar

Financial Select Sector

Verizon Communications

Bank of America

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約